SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-216859
Filing Date
2019-08-08
Accepted
2019-08-08 16:18:10
Documents
69
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d701234d10q.htm 10-Q 880625
2 EX-10.1 d701234dex101.htm EX-10.1 15526
3 EX-31.1 d701234dex311.htm EX-31.1 9326
4 EX-31.2 d701234dex312.htm EX-31.2 9158
5 EX-32.1 d701234dex321.htm EX-32.1 5311
  Complete submission text file 0001193125-19-216859.txt   6081489

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snna-20190630.xml EX-101.INS 1389821
7 XBRL TAXONOMY EXTENSION SCHEMA snna-20190630.xsd EX-101.SCH 48890
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snna-20190630_cal.xml EX-101.CAL 38539
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snna-20190630_def.xml EX-101.DEF 230286
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE snna-20190630_lab.xml EX-101.LAB 480490
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snna-20190630_pre.xml EX-101.PRE 366003
Mailing Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362
Business Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362 (818) 629-2256
Sienna Biopharmaceuticals, Inc. (Filer) CIK: 0001656328 (see all company filings)

IRS No.: 273364627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38155 | Film No.: 191009781
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences